Literature DB >> 9068760

Low dose UVA1 phototherapy in disabling pansclerotic morphoea of childhood.

C Gruss, M Stücker, G Kobyletzki, D Schreiber, P Altmeyer, M Kerscher.   

Abstract

Mesh：

Year:  1997        PMID： 9068760     DOI： 10.1111/j.1365-2133.1997.tb14925.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  7 in total

Review 1.  Challenges in the diagnosis and treatment of disabling pansclerotic morphea of childhood: case-based review.

Authors:  Han Jie Soh; Courtney Samuel; Victoria Heaton; William Douglas Renton; Angela Cox; Jane Munro
Journal:  Rheumatol Int       Date:  2019-03-05       Impact factor: 2.631

2.  Low-dose Ultraviolet A1 Phototherapy for Treating Pityriasis Rosea.

Authors:  Sang Hee Lim; Sang Min Kim; Byung Ho Oh; Jong Hyun Ko; Yang Won Lee; Yong Beom Choe; Kyu Joong Ahn
Journal:  Ann Dermatol       Date:  2009-08-31       Impact factor: 1.444

3.  Pansclerotic morphea in childhood: a case report.

Authors:  T Doede; U Wollina; W Hindermann; F Schier; M Bondartschuk
Journal:  Pediatr Surg Int       Date:  2003-06-21       Impact factor: 1.827

Review 4.  UVA/UVA1 phototherapy and PUVA photochemotherapy in connective tissue diseases and related disorders: a research based review.

Authors:  Frank Breuckmann; Thilo Gambichler; Peter Altmeyer; Alexander Kreuter
Journal:  BMC Dermatol       Date:  2004-09-20

Review 5.  Ultraviolet A1 Phototherapy for Fibrosing Conditions.

Authors:  Thilo Gambichler; Lutz Schmitz
Journal:  Front Med (Lausanne)       Date:  2018-08-27

6.  Disabling pansclerotic morphea of childhood with extracutaneous manifestations.

Authors:  Mahendra M Kura; Saurabh R Jindal
Journal:  Indian J Dermatol       Date:  2013-03       Impact factor: 1.494

Review 7.  Phototherapy in Scleroderma.

Authors:  John Hassani; Steven R Feldman
Journal:  Dermatol Ther (Heidelb)       Date:  2016-08-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.